Evommune, Inc. - Common Stock, $0.0001 par value per share (EVMN) Institutional Ownership

13F Institutional Holders and Ownership History for Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
EVMN on NYSE
Shares outstanding
35,974,918
Price per share
$21.65
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
27,200,904
Total reported value
$465,685,578
% of total 13F portfolios
0.01%
Share change
+23,579,060
Value change
+$403,679,610
Number of holders
59
Price from insider filings
$21.65
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evommune, Inc. - Common Stock, $0.0001 par value per share (EVMN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LSP 7 Cooperative UA 15% -6.2% $114,491,976 +$7,765,422 5,288,313 +7.3% LSP 7 Cooperatieve U.A. 12 Feb 2026
RA CAPITAL MANAGEMENT, L.P. 9.7% -12% $70,347,063 +$722,023 3,494,638 +1% RA Capital Management, L.P. 12 Feb 2026
Pivotal bioVenture Partners Fund I, L.P. 11% $69,158,608 3,435,599 Nan Fung Group Holdings Limited 31 Dec 2025
Andera Partners 6% 1,897,362 Andera Partners 07 Nov 2025

As of 31 Dec 2025, 59 institutional investors reported holding 27,200,904 shares of Evommune, Inc. - Common Stock, $0.0001 par value per share (EVMN). This represents 76% of the company’s total 35,974,918 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Evommune, Inc. - Common Stock, $0.0001 par value per share (EVMN) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
EQT Fund Management S.a r.l. 14% 4,929,633 7.6% $84,395,317
RA CAPITAL MANAGEMENT, L.P. 9.6% 3,458,770 0.61% $59,214,142
Pivotal bioVenture Partners Investment Advisor LLC 5.4% 1,926,943 13% $32,989,264
ANDERA PARTNERS 5.3% 1,897,362 0% 18% $32,482,837
Nan Fung Group Holdings Ltd 4% 1,441,032 22% $24,670,468
JPMORGAN CHASE & CO 3.6% 1,308,901 0% $22,408,385
RTW INVESTMENTS, LP 3.6% 1,283,671 0.22% $21,976,448
SymBiosis Capital Partners, LLC 3.6% 1,280,778 0% 23% $21,926,919
MARSHALL WACE, LLP 2.7% 988,200 0.02% $16,917,986
EVENTIDE ASSET MANAGEMENT, LLC 2.7% 961,525 0.26% $16,461,308
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% 782,121 0% $13,391,000
SECTORAL ASSET MANAGEMENT INC 1.6% 589,005 8.1% $10,083,766
Verition Fund Management LLC 1.6% 565,214 0.05% $9,676,464
Aberdeen Group plc 1.5% 525,376 0.01% $8,994,437
Velan Capital Investment Management LP 1.4% 506,754 5% $8,675,628
VANGUARD GROUP INC 1.4% 502,574 0% $8,604,067
Octagon Capital Advisors LP 1.4% 500,000 1.1% $8,560,000
AMERICAN CENTURY COMPANIES INC 1.2% 417,455 0% $7,146,850
FEDERATED HERMES, INC. 0.9% 325,000 0.01% $5,564,000
GREAT POINT PARTNERS LLC 0.9% 325,000 1.8% $5,564,000
NEXTBio Capital Management LP 0.63% 228,286 0% 2.3% $3,908,256
Defilade Capital Management, L.P. 0.6% 215,418 0% 0.5% $3,687,956
Kynam Capital Management, LP 0.52% 185,482 0.21% $3,175,452
ADAR1 Capital Management, LLC 0.51% 184,062 0.24% $3,151,141
Monashee Investment Management LLC 0.51% 183,239 1.8% $3,137,052

Institutional Holders of Evommune, Inc. - Common Stock, $0.0001 par value per share (EVMN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 27,200,904 $465,685,578 +$403,679,610 $17.12 59